Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579618 · ClinicalTrials.gov registry record
Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 53
- Enrollment target
NCT00579618: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579618 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579618 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to help us learn more about the roles of genes in cancers. Genes are short pieces of DNA which determine the inherited characteristics that distinguish one individual from another. This study will look at how some genes might raise or lower the chance some people may develop cancer. The sample collection will help generate the materials needed for this study.
Interventions
- OTHER Saliva or Blood samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2006-09 |
| Est. Completion | 2017-07 |
What the finished NCT00579618 record still lists
NCT00579618 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Saliva or Blood samples is the first listed.
NCT00579618 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579618 about?
NCT00579618 is a clinical study titled "Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging". The purpose of this study is to help us learn more about the roles of genes in cancers. Genes are short pieces of DNA which determine the inherited characteristics that distinguish one individual from another. This study will look at how some genes might raise or lower the chance some people may dev...
What is the current status of trial NCT00579618?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2006-09. Estimated completion is 2017-07.
What interventions are being tested in trial NCT00579618?
The interventions under investigation include: Saliva or Blood samples (OTHER).
Who is sponsoring clinical trial NCT00579618?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia